furosemide has been researched along with pentoxifylline in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (6.25) | 18.7374 |
1990's | 4 (25.00) | 18.2507 |
2000's | 6 (37.50) | 29.6817 |
2010's | 5 (31.25) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Burris, SM; Geor, RJ; Smith, CM; Weiss, DJ | 1 |
KochmaĆski, M; Zochowski, RJ | 1 |
Weithmann, KU | 1 |
Evanson, OA; Geor, RJ; Weiss, DJ | 1 |
Geor, RJ; Weiss, DJ | 1 |
Goetz, TE; Humphrey, S; Manohar, M; Rothenbaum, P | 1 |
Mishnev, A; Stepanovs, D | 1 |
2 review(s) available for furosemide and pentoxifylline
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drugs affecting the hematologic system of the performance horse.
Topics: Animals; Blood Cells; Blood Coagulation; Blood Platelets; Blood Volume; Erythropoiesis; Furosemide; Hematinics; Horses; Pentoxifylline; Physical Conditioning, Animal; Rheology | 1993 |
14 other study(ies) available for furosemide and pentoxifylline
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effects of furosemide and pentoxifylline on blood flow properties in horses.
Topics: Animals; Blood Cell Count; Blood Circulation; Blood Viscosity; Epinephrine; Female; Furosemide; Horses; Male; Pentoxifylline | 1992 |
[The effect of combined treatment in chronic congestive heart failure with digoxin, furosemide and pentoxifylline upon blood viscosity].
Topics: Adult; Aged; Blood Viscosity; Digoxin; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pentoxifylline | 1990 |
Effects of furosemide on prostacyclin-like antiaggregatory release from vessel wall and renal cortex.
Topics: Animals; Aorta; Aspirin; Blood Vessels; Epoprostenol; Female; Furosemide; In Vitro Techniques; Indomethacin; Kidney Cortex; Pentoxifylline; Platelet Aggregation; Prostaglandins; Rats; Rats, Inbred Strains | 1982 |
The effects of furosemide and pentoxifylline on the flow properties of equine erythrocytes: in vitro studies.
Topics: Animals; Blood Viscosity; Erythrocyte Indices; Erythrocytes; Furosemide; Horses; Pentoxifylline; Potassium; Regional Blood Flow | 1994 |
Intravenous pentoxifylline does not enhance the pulmonary haemodynamic efficacy of frusemide in strenuously exercising thoroughbred horses.
Topics: Animals; Breeding; Diuretics; Drug Administration Schedule; Drug Interactions; Female; Furosemide; Hemodynamics; Horse Diseases; Horses; Hypertension, Pulmonary; Injections, Intravenous; Male; Pentoxifylline; Physical Conditioning, Animal; Pulmonary Circulation; Random Allocation; Vasodilator Agents | 2001 |
Multicomponent pharmaceutical cocrystals: furosemide and pentoxifylline.
Topics: Crystallography, X-Ray; Furosemide; Hydrogen Bonding; Molecular Structure; Pentoxifylline | 2012 |